ESR1 and endometriosis: Using experimental mouse models of endometriosis which incorporate genetically modified mice in which ER-α and ER-β are conditionally deleted, these investigators demonstrated that use of the ER-β antagonist, PHTPP, was associated with a regression of ectopic lesions.